Results 11 to 20 of about 3,933 (187)

Treatment strategies in mucous membrane pemphigoid

open access: yesTherapeutics and Clinical Risk Management, 2008
Ann G Neff, Matthew Turner, Diya F MutasimDepartment of Dermatology, University of Cincinnati, Cincinnati, OH, USAAbstract: Mucous membrane pemphigoid (MMP) is an autoimmune blistering disorder that is characterized by subepithelial bullae.
Ann G Neff   +2 more
doaj   +5 more sources

Mucous Membrane Pemphigoid with Tracheal Involvement [PDF]

open access: yesCase Reports in Pulmonology, 2016
34-year-old African American female with history of pemphigoid presented with hemoptysis. Patient was found to have mucous membrane pemphigoid involving the oropharynx and extending to trachea, till just above main stem carina. Four other cases described
Arash Minaie, Salim R. Surani
doaj   +2 more sources

Structured Diagnostic Approach and Risk Assessment in Mucous Membrane Pemphigoid with Oesophageal Involvement

open access: yesActa Dermato-Venereologica, 2018
Oesophageal involvement in mucous membrane pemphigoid is considered rare, but it may be underdiagnosed. To assess the incidence of oesophageal involvement in a group of patients with newly diagnosed mucous membrane pemphigoid we retrospectively analysed ...
Sandrine Benoit   +3 more
doaj   +2 more sources

Oral Mucous Membrane Pemphigoid With Positive Nikolsky’s Sign: A Case Report

open access: yesActa Medica Iranica, 2021
Mucous membrane pemphigoid (MMP) is a rare inflammatory, autoimmune, and subepithelial vesiculobullous disease in which tissue-bound autoantibodies are produced against one or more components of the basement membrane. Oral lesions of the pemphigoid begin
Narjes Akbari   +2 more
doaj   +3 more sources

Mucous membrane pemphigoid in a patient with hypertension treated with atenolol: a case report

open access: yesJournal of Medical Case Reports, 2012
Introduction Atenolol is commonly used by patients with hypertension, angina pectoris, or myocardial infarction. There have been reports of various adverse effects associated with the use of atenolol including bullous pemphigoid.
Kanjanabuch Patnarin   +3 more
doaj   +2 more sources

A Case of Severe and Refractory Membranous Nephropathy Associated to Mucous Membrane Pemphigoid

open access: yesCase Reports in Nephrology, 2021
Primary membranous nephropathy (MN) and mucous membrane pemphigoid (MMP) are two autoimmune conditions with well-defined diagnostic and treatment guidelines.
Eric Mereniuk   +2 more
doaj   +2 more sources

Rituximab and bilateral HSV epithelial keratitis in a patient with mucous membrane pemphigoid [PDF]

open access: yesJournal of Ophthalmic Inflammation and Infection, 2018
Background B cell depleting therapy is widely used for lymphoproliferative diseases and immune-mediated disorders, including mucous membrane pemphigoid.
W. Bernauer, S. Schuler, L. Borradori
doaj   +2 more sources

Coexistence of mucous membrane pemphigoid and vitiligo

open access: yesIndian Dermatology Online Journal, 2014
Mucous membrane pemphigoid describes a rare heterogeneous group of chronic, inflammatory, mucous membrane-dominated, subepithelial blistering diseases that manifest a varying constellation of oral, ocular, skin, genital, nasopharyngeal, esophageal, and ...
Sanath Aithal   +2 more
doaj   +2 more sources

Two pemphigoid cases with mucous membrane involvement successfully treated with baricitinib

open access: yesJEADV Clinical Practice
Both bullous pemphigoid and mucous membrane pemphigoid are autoimmune bullous diseases that can be challenging to treat in individual cases. Janus kinase inhibitors have shown efficacy in several autoimmune and inflammatory diseases, although these drugs
Tamás Malkovics   +2 more
doaj   +2 more sources

Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature

open access: yesFrontiers in Medicine, 2018
An 83-year-old patient developed erosions and a blister of the gingival mucous membrane, 6 months after discontinuation of the anti-programmed death-1 (anti PD-1) pembrolizumab therapy administered for 10 months for a metastatic melanoma.
Coralie Zumelzu   +12 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy